Ochratoxin A, citrinin and deoxynivalenol decrease claudin-2 expression in mouse rectum CMT93-II cells

Microscopy
Hideaki NakayamaT Inai

Abstract

Intestinal epithelial cells are the first targets of ingested mycotoxins, such as ochratoxin A, citrinin and deoxynivalenol. It has been reported that paracellular permeability regulated by tight junctions is modulated by several mycotoxins by reducing the expression of specific claudins and integral membrane proteins in cell-cell contacts, accompanied by increase in phosphorylation of mitogen-activated protein kinases, including extracellular signal-related kinase (ERK) 1/2, p38 and c-Jun NH2-terminal protein kinase. Claudin-2 is expressed in the deep crypt cells, but not in the villus/surface cells in vivo. While Caco-2, T84 and IPEC-J2 cells, which are widely used intestinal epithelial cell lines to assess the influence of mycotoxins, do not express claudin-2, CMT93-II cells express claudin-2. We previously reported that inhibition of the ERK pathway reduced claudin-2 levels in cell-cell contacts in CMT93-II cells. In this study, we examined whether ochratoxin A, citrinin and deoxynivalenol affect claudin-2 expression and ERK1/2 phosphorylation in CMT93-II cells. We found that all mycotoxins reduced claudin-2 expression in cell-cell contacts, with reduction (by citrinin and deoxynivalenol) or no change (by ochratoxin A) in p...Continue Reading

References

Jan 1, 1978·The Journal of Pathology·L M Franks, V J Hemmings
Dec 1, 1992·Journal of Animal Science·R R Marquardt, A A Frohlich
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·B GumbinerD Apatira
Jun 15, 1982·Toxicology and Applied Pharmacology·S Kumagai, K Aibara
May 1, 1995·Food Additives and Contaminants·C MiccoA Ambruzzi
Dec 1, 1993·The Journal of Cell Biology·M FuruseS Tsukita
Feb 11, 2000·European Journal of Cell Biology·T InaiY Shibata
Jun 2, 2000·Gastroenterology·T KinugasaH C Reinecker
May 8, 2001·Food Additives and Contaminants·M A SkaugO D Saugstad
Nov 15, 2002·Journal of Cell Science·Salah AmashehMichael Fromm
Sep 18, 2003·American Journal of Physiology. Renal Physiology·Christina M Van ItallieJames M Anderson
Jul 2, 2004·American Journal of Physiology. Cell Physiology·John McLaughlinCatherine A O'Neill
Sep 3, 2004·Toxicology Letters·John Christian LarsenPeter Ruckenbauer
Jul 12, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Shyam PrasadJane E Collins
Jul 16, 2005·Food Additives and Contaminants·I P OswaldF Accensi
Sep 15, 2005·Cell and Tissue Research·Salah AmashehMichael Fromm
Dec 21, 2005·The Journal of Cell Biology·Junichi IkenouchiShoichiro Tsukita
Jun 29, 2006·American Journal of Physiology. Renal Physiology·Christina M Van ItallieJames M Anderson
May 15, 2007·Biochemical and Biophysical Research Communications·Daniel LambertCatherine A O'Neill
Jan 30, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Mathilde Body-MalapelPhilippe Mathurin
Sep 12, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·David SasMichel Baum
Feb 25, 2009·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·J J Pestka
Mar 18, 2009·Toxicology and Applied Pharmacology·Philippe PintonIsabelle P Oswald
Mar 31, 2009·International Journal of Molecular Sciences·Masayo Kushiro
Apr 23, 2009·Journal of Cell Science·Dorothee GünzelDominik Müller
Apr 7, 2010·Toxicology and Applied Pharmacology·Jacqueline Van De WalleYvan Larondelle
Jul 27, 2010·Biochimica Et Biophysica Acta·Susanne MilatzMichael Fromm

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.